Equities research analysts expect Albemarle Corporation (NYSE:ALB) to report earnings of $1.07 per share for the current fiscal quarter, Zacks Investment Research reports. Six analysts have provided estimates for Albemarle Corporation’s earnings, with estimates ranging from $1.05 to $1.13. Albemarle Corporation reported earnings per share of $0.91 during the same quarter last year, which would suggest a positive year-over-year growth rate of 17.6%. The company is scheduled to report its next earnings results on Monday, November 6th.

According to Zacks, analysts expect that Albemarle Corporation will report full year earnings of $4.36 per share for the current year, with EPS estimates ranging from $4.32 to $4.40. For the next year, analysts anticipate that the business will post earnings of $5.02 per share, with EPS estimates ranging from $4.74 to $5.20. Zacks Investment Research’s EPS averages are an average based on a survey of analysts that cover Albemarle Corporation.

Albemarle Corporation (NYSE:ALB) last released its quarterly earnings data on Monday, August 7th. The specialty chemicals company reported $1.13 EPS for the quarter, beating the consensus estimate of $1.11 by $0.02. Albemarle Corporation had a return on equity of 11.59% and a net margin of 31.49%. The company had revenue of $737.25 million for the quarter, compared to analysts’ expectations of $735.50 million. During the same period last year, the firm posted $0.93 earnings per share. Albemarle Corporation’s revenue was up 10.1% compared to the same quarter last year.

A number of analysts have recently weighed in on ALB shares. Jefferies Group LLC raised their price objective on Albemarle Corporation from $144.00 to $156.00 and gave the stock a “buy” rating in a research report on Thursday, September 21st. Royal Bank Of Canada reaffirmed a “buy” rating and set a $136.00 target price on shares of Albemarle Corporation in a research report on Wednesday, September 20th. Robert W. Baird lowered Albemarle Corporation from an “outperform” rating to a “neutral” rating and upped their target price for the company from $134.29 to $135.00 in a research report on Monday, September 25th. They noted that the move was a valuation call. Loop Capital began coverage on Albemarle Corporation in a research note on Thursday, September 28th. They issued a “buy” rating and a $150.00 price target for the company. Finally, Instinet increased their price target on Albemarle Corporation from $134.00 to $146.00 and gave the company a “buy” rating in a research note on Monday, September 18th. Eight analysts have rated the stock with a hold rating, eleven have issued a buy rating and one has issued a strong buy rating to the stock. The company has a consensus rating of “Buy” and a consensus target price of $115.11.

COPYRIGHT VIOLATION NOTICE: “Albemarle Corporation (ALB) Expected to Post Earnings of $1.07 Per Share” was originally published by American Banking News and is owned by of American Banking News. If you are accessing this report on another publication, it was illegally stolen and republished in violation of United States and international trademark and copyright legislation. The correct version of this report can be viewed at https://www.americanbankingnews.com/2017/10/04/albemarle-corporation-alb-expected-to-post-earnings-of-1-07-per-share-2.html.

In related news, EVP Karen G. Narwold sold 11,500 shares of the business’s stock in a transaction on Wednesday, August 23rd. The shares were sold at an average price of $115.95, for a total transaction of $1,333,425.00. Following the completion of the transaction, the executive vice president now directly owns 36,620 shares in the company, valued at $4,246,089. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Chairman Luther C. Iv Kissam sold 50,000 shares of the company’s stock in a transaction on Friday, July 7th. The shares were sold at an average price of $110.08, for a total transaction of $5,504,000.00. Following the completion of the sale, the chairman now directly owns 252,917 shares in the company, valued at $27,841,103.36. The disclosure for this sale can be found here. In the last three months, insiders have sold 91,897 shares of company stock valued at $10,215,486. 0.74% of the stock is currently owned by corporate insiders.

A number of institutional investors and hedge funds have recently made changes to their positions in ALB. Carroll Financial Associates Inc. raised its stake in shares of Albemarle Corporation by 0.3% during the 2nd quarter. Carroll Financial Associates Inc. now owns 982 shares of the specialty chemicals company’s stock valued at $103,000 after buying an additional 3 shares during the last quarter. Benjamin F. Edwards & Company Inc. lifted its holdings in shares of Albemarle Corporation by 0.3% in the 2nd quarter. Benjamin F. Edwards & Company Inc. now owns 1,458 shares of the specialty chemicals company’s stock valued at $154,000 after buying an additional 4 shares during the period. Scotia Capital Inc. lifted its holdings in shares of Albemarle Corporation by 0.5% in the 2nd quarter. Scotia Capital Inc. now owns 2,022 shares of the specialty chemicals company’s stock valued at $213,000 after buying an additional 10 shares during the period. Alps Advisors Inc. lifted its holdings in shares of Albemarle Corporation by 0.3% in the 2nd quarter. Alps Advisors Inc. now owns 4,606 shares of the specialty chemicals company’s stock valued at $486,000 after buying an additional 12 shares during the period. Finally, Northwestern Mutual Wealth Management Co. lifted its holdings in shares of Albemarle Corporation by 2.1% in the 2nd quarter. Northwestern Mutual Wealth Management Co. now owns 968 shares of the specialty chemicals company’s stock valued at $102,000 after buying an additional 20 shares during the period. 83.77% of the stock is currently owned by institutional investors.

Albemarle Corporation (NYSE:ALB) opened at 137.42 on Wednesday. The stock has a market cap of $15.18 billion, a price-to-earnings ratio of 17.58 and a beta of 1.66. Albemarle Corporation has a 12 month low of $76.32 and a 12 month high of $137.83. The firm has a 50-day moving average price of $122.99 and a 200-day moving average price of $113.52.

The firm also recently disclosed a quarterly dividend, which was paid on Monday, October 2nd. Stockholders of record on Friday, September 15th were issued a $0.32 dividend. This represents a $1.28 annualized dividend and a dividend yield of 0.93%. The ex-dividend date was Thursday, September 14th. Albemarle Corporation’s dividend payout ratio (DPR) is currently 16.41%.

About Albemarle Corporation

Albemarle Corporation is a global developer, manufacturer and marketer of highly-engineered specialty chemicals. The Company operates through three segments: Lithium and Advanced Materials, Bromine Specialties and Refining Solutions. Lithium and Advanced Materials segment consist of two product categories: Lithium and Performance Catalyst Solutions.

Get a free copy of the Zacks research report on Albemarle Corporation (ALB)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Albemarle Corporation (NYSE:ALB)

Receive News & Ratings for Albemarle Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Albemarle Corporation and related companies with MarketBeat.com's FREE daily email newsletter.